Cargando…
A pilot open-label trial of minocycline in patients with autism and regressive features
BACKGROUND: Minocycline is a tetracycline derivative that readily crosses the blood brain barrier and appears to have beneficial effects on neuroinflammation, microglial activation and neuroprotection in a variety of neurological disorders. Both microglial activation and neuroinflammation have been...
Autores principales: | Pardo, Carlos A, Buckley, Ashura, Thurm, Audrey, Lee, Li-Ching, Azhagiri, Arun, Neville, David M, Swedo, Susan E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663771/ https://www.ncbi.nlm.nih.gov/pubmed/23566357 http://dx.doi.org/10.1186/1866-1955-5-9 |
Ejemplares similares
-
The importance of autism research
por: Thurm, Audrey, et al.
Publicado: (2012) -
State-Dependent Differences in Functional Connectivity in Young Children With Autism Spectrum Disorder
por: Buckley, Ashura W., et al.
Publicado: (2015) -
Classifying and characterizing the development of adaptive behavior in a naturalistic longitudinal study of young children with autism
por: Farmer, Cristan, et al.
Publicado: (2018) -
No evidence of antibodies against GAD65 and other specific antigens in children with autism
por: Kalra, Simran, et al.
Publicado: (2015) -
An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome
por: Grieco, Joseph C, et al.
Publicado: (2014)